Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 6/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7494525 | 0.79 | KCNH2 (0.34) | KCNH2 | |
| SCHEMBL7995325 | 0.79 | STAT3 (0.36) | KCNH2 | |
| SCHEMBL7842251 | 0.79 | STAT3 (0.36) | KCNH2 | |
| Hydrochloric Acid SCHEMBL7847229 | 0.79 | KCNH2 (0.34) | KCNH2 | |
| SCHEMBL7492130 | 0.78 | KCNH2 (0.53) | KCNH2 | |
| Hydrochloric Acid SCHEMBL7836191 | 0.77 | KCNH2 (0.52) | KCNH2 | |
| Hydrochloric Acid SCHEMBL7843178 | 0.77 | KCNH2 (0.52) | KCNH2 | |
| SCHEMBL7495552 | 0.76 | KCNH2 (0.42) | KCNH2 | |
| Hydrochloric Acid SCHEMBL7494677 | 0.76 | KCNH2 (0.41) | KCNH2 | |
| Bicarbonate SCHEMBL7496529 | 0.75 | KCNH2 (0.36) | KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010036941-A1 | Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolonecarboxylic acid and -naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and associated gastroduodenal disorders | PETERSEN UWE (DE) | 2001-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010036941-A1 | Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolonecarboxylic acid and -naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and associated gastroduodenal disorders | OXER1, AOC3, PAM | KCNH2 3936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.